Bank Of Montreal Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Bank Of Montreal

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	BUY	$144.95 - $152.29 $1.47 Million - $1.55 Million	10,150 Added 22.57%	55,117 $8.36 Million
Q2 2022 Aug 11, 2022	BUY	$83.14 - $145.99 $3.74 Million - $6.56 Million	44,967 New	44,967 $6.51 Million
Q1 2022 May 12, 2022	SELL	$110.08 - $142.92 $1.21 Million - $1.57 Million	-10,966 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$99.73 - $148.48 $348,257 - $518,492	-3,492 Reduced 24.15%	10,966 $1.53 Million
Q3 2021 Nov 12, 2021	BUY	$98.85 - $138.91 $1.43 Million - $2.01 Million	14,458 New	14,458 $1.91 Million

792K

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.18B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

Stay updated on Bank Of Montreal with notifications on news.